img

Global Anticoagulant Reversal Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Anticoagulant Reversal Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Anticoagulant reversal drugs are required to reverse the effect of anticoagulation in certain situations such as unplanned surgery, overdose of anticoagulant therapy, and uncontrolled bleeding.
Anticoagulant Reversal Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anticoagulant Reversal Drug market is projected to reach US$ 2259.5 million in 2034, increasing from US$ 1444.8 million in 2022, with the CAGR of 6.5% during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
Asia Pacific is anticipated to dominate the global market over the forecast period owing to its high demand in the region.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anticoagulant Reversal Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bausch Health Companies
Pfizer
Fresenius Kabi
Amneal Pharmaceuticals
Boehringer Ingelheim
CSL
Octapharma
Portola Pharmaceuticals
Perosphere Pharmaceuticals
Segment by Type
Prothrombin Complex Concentrates
Vitamin K
Protamine
Tranexamic Acid

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Anticoagulant Reversal Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Anticoagulant Reversal Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Anticoagulant Reversal Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Anticoagulant Reversal Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Anticoagulant Reversal Drug introduction, etc. Anticoagulant Reversal Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Anticoagulant Reversal Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Anticoagulant Reversal Drug Market Overview
1.1 Anticoagulant Reversal Drug Product Overview
1.2 Anticoagulant Reversal Drug Market Segment by Type
1.2.1 Prothrombin Complex Concentrates
1.2.2 Vitamin K
1.2.3 Protamine
1.2.4 Tranexamic Acid
1.3 Global Anticoagulant Reversal Drug Market Size by Type
1.3.1 Global Anticoagulant Reversal Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Anticoagulant Reversal Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Anticoagulant Reversal Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anticoagulant Reversal Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Anticoagulant Reversal Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Anticoagulant Reversal Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Anticoagulant Reversal Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Anticoagulant Reversal Drug Sales Breakdown by Type (2018-2024)
2 Global Anticoagulant Reversal Drug Market Competition by Company
2.1 Global Top Players by Anticoagulant Reversal Drug Sales (2018-2024)
2.2 Global Top Players by Anticoagulant Reversal Drug Revenue (2018-2024)
2.3 Global Top Players by Anticoagulant Reversal Drug Price (2018-2024)
2.4 Global Top Manufacturers Anticoagulant Reversal Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anticoagulant Reversal Drug Market Competitive Situation and Trends
2.5.1 Anticoagulant Reversal Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Anticoagulant Reversal Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anticoagulant Reversal Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Anticoagulant Reversal Drug Market
2.8 Key Manufacturers Anticoagulant Reversal Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anticoagulant Reversal Drug Status and Outlook by Region
3.1 Global Anticoagulant Reversal Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Anticoagulant Reversal Drug Historic Market Size by Region
3.2.1 Global Anticoagulant Reversal Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Anticoagulant Reversal Drug Sales in Value by Region (2018-2024)
3.2.3 Global Anticoagulant Reversal Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Anticoagulant Reversal Drug Forecasted Market Size by Region
3.3.1 Global Anticoagulant Reversal Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Anticoagulant Reversal Drug Sales in Value by Region (2024-2034)
3.3.3 Global Anticoagulant Reversal Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Anticoagulant Reversal Drug by Application
4.1 Anticoagulant Reversal Drug Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Others
4.2 Global Anticoagulant Reversal Drug Market Size by Application
4.2.1 Global Anticoagulant Reversal Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Anticoagulant Reversal Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Anticoagulant Reversal Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anticoagulant Reversal Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Anticoagulant Reversal Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Anticoagulant Reversal Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Anticoagulant Reversal Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Anticoagulant Reversal Drug Sales Breakdown by Application (2018-2024)
5 North America Anticoagulant Reversal Drug by Country
5.1 North America Anticoagulant Reversal Drug Historic Market Size by Country
5.1.1 North America Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Anticoagulant Reversal Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Anticoagulant Reversal Drug Sales in Value by Country (2018-2024)
5.2 North America Anticoagulant Reversal Drug Forecasted Market Size by Country
5.2.1 North America Anticoagulant Reversal Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Anticoagulant Reversal Drug Sales in Value by Country (2024-2034)
6 Europe Anticoagulant Reversal Drug by Country
6.1 Europe Anticoagulant Reversal Drug Historic Market Size by Country
6.1.1 Europe Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Anticoagulant Reversal Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Anticoagulant Reversal Drug Sales in Value by Country (2018-2024)
6.2 Europe Anticoagulant Reversal Drug Forecasted Market Size by Country
6.2.1 Europe Anticoagulant Reversal Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Anticoagulant Reversal Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Anticoagulant Reversal Drug by Region
7.1 Asia-Pacific Anticoagulant Reversal Drug Historic Market Size by Region
7.1.1 Asia-Pacific Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Anticoagulant Reversal Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Anticoagulant Reversal Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Anticoagulant Reversal Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Anticoagulant Reversal Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Anticoagulant Reversal Drug Sales in Value by Region (2024-2034)
8 Latin America Anticoagulant Reversal Drug by Country
8.1 Latin America Anticoagulant Reversal Drug Historic Market Size by Country
8.1.1 Latin America Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Anticoagulant Reversal Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Anticoagulant Reversal Drug Sales in Value by Country (2018-2024)
8.2 Latin America Anticoagulant Reversal Drug Forecasted Market Size by Country
8.2.1 Latin America Anticoagulant Reversal Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Anticoagulant Reversal Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Anticoagulant Reversal Drug by Country
9.1 Middle East and Africa Anticoagulant Reversal Drug Historic Market Size by Country
9.1.1 Middle East and Africa Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Anticoagulant Reversal Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Anticoagulant Reversal Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Anticoagulant Reversal Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Anticoagulant Reversal Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Anticoagulant Reversal Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bausch Health Companies
10.1.1 Bausch Health Companies Company Information
10.1.2 Bausch Health Companies Introduction and Business Overview
10.1.3 Bausch Health Companies Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bausch Health Companies Anticoagulant Reversal Drug Products Offered
10.1.5 Bausch Health Companies Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Pfizer Anticoagulant Reversal Drug Products Offered
10.2.5 Pfizer Recent Development
10.3 Fresenius Kabi
10.3.1 Fresenius Kabi Company Information
10.3.2 Fresenius Kabi Introduction and Business Overview
10.3.3 Fresenius Kabi Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Fresenius Kabi Anticoagulant Reversal Drug Products Offered
10.3.5 Fresenius Kabi Recent Development
10.4 Amneal Pharmaceuticals
10.4.1 Amneal Pharmaceuticals Company Information
10.4.2 Amneal Pharmaceuticals Introduction and Business Overview
10.4.3 Amneal Pharmaceuticals Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Amneal Pharmaceuticals Anticoagulant Reversal Drug Products Offered
10.4.5 Amneal Pharmaceuticals Recent Development
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Company Information
10.5.2 Boehringer Ingelheim Introduction and Business Overview
10.5.3 Boehringer Ingelheim Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Boehringer Ingelheim Anticoagulant Reversal Drug Products Offered
10.5.5 Boehringer Ingelheim Recent Development
10.6 CSL
10.6.1 CSL Company Information
10.6.2 CSL Introduction and Business Overview
10.6.3 CSL Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 CSL Anticoagulant Reversal Drug Products Offered
10.6.5 CSL Recent Development
10.7 Octapharma
10.7.1 Octapharma Company Information
10.7.2 Octapharma Introduction and Business Overview
10.7.3 Octapharma Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Octapharma Anticoagulant Reversal Drug Products Offered
10.7.5 Octapharma Recent Development
10.8 Portola Pharmaceuticals
10.8.1 Portola Pharmaceuticals Company Information
10.8.2 Portola Pharmaceuticals Introduction and Business Overview
10.8.3 Portola Pharmaceuticals Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Portola Pharmaceuticals Anticoagulant Reversal Drug Products Offered
10.8.5 Portola Pharmaceuticals Recent Development
10.9 Perosphere Pharmaceuticals
10.9.1 Perosphere Pharmaceuticals Company Information
10.9.2 Perosphere Pharmaceuticals Introduction and Business Overview
10.9.3 Perosphere Pharmaceuticals Anticoagulant Reversal Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Perosphere Pharmaceuticals Anticoagulant Reversal Drug Products Offered
10.9.5 Perosphere Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anticoagulant Reversal Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anticoagulant Reversal Drug Industrial Chain Analysis
11.4 Anticoagulant Reversal Drug Market Dynamics
11.4.1 Anticoagulant Reversal Drug Industry Trends
11.4.2 Anticoagulant Reversal Drug Market Drivers
11.4.3 Anticoagulant Reversal Drug Market Challenges
11.4.4 Anticoagulant Reversal Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anticoagulant Reversal Drug Distributors
12.3 Anticoagulant Reversal Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Prothrombin Complex Concentrates
Table 2. Major Company of Vitamin K
Table 3. Major Company of Protamine
Table 4. Major Company of Tranexamic Acid
Table 5. Global Anticoagulant Reversal Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Anticoagulant Reversal Drug Sales by Type (2018-2024) & (K Units)
Table 7. Global Anticoagulant Reversal Drug Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Anticoagulant Reversal Drug Sales by Type (2018-2024) & (US& Million)
Table 9. Global Anticoagulant Reversal Drug Market Share in Value by Type (2018-2024)
Table 10. Global Anticoagulant Reversal Drug Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Anticoagulant Reversal Drug Sales by Type (2024-2034) & (K Units)
Table 12. Global Anticoagulant Reversal Drug Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Anticoagulant Reversal Drug Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Anticoagulant Reversal Drug Sales Market Share in Value by Type (2024-2034)
Table 15. Global Anticoagulant Reversal Drug Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Anticoagulant Reversal Drug Sales by Type (2018-2024) & (K Units)
Table 17. North America Anticoagulant Reversal Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Anticoagulant Reversal Drug Sales (K Units) by Type (2018-2024)
Table 19. Europe Anticoagulant Reversal Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Anticoagulant Reversal Drug Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Anticoagulant Reversal Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Anticoagulant Reversal Drug Sales (K Units) by Type (2018-2024)
Table 23. Latin America Anticoagulant Reversal Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Anticoagulant Reversal Drug Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Anticoagulant Reversal Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Anticoagulant Reversal Drug Sales by Company (2018-2024) & (K Units)
Table 27. Global Anticoagulant Reversal Drug Sales Share by Company (2018-2024)
Table 28. Global Anticoagulant Reversal Drug Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Anticoagulant Reversal Drug Revenue Share by Company (2018-2024)
Table 30. Global Market Anticoagulant Reversal Drug Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Anticoagulant Reversal Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Anticoagulant Reversal Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anticoagulant Reversal Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Anticoagulant Reversal Drug Market
Table 35. Key Manufacturers Anticoagulant Reversal Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Anticoagulant Reversal Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Anticoagulant Reversal Drug Sales by Region (2018-2024) & (K Units)
Table 39. Global Anticoagulant Reversal Drug Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Anticoagulant Reversal Drug Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Anticoagulant Reversal Drug Sales Market Share in Value by Region (2018-2024)
Table 42. Global Anticoagulant Reversal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Anticoagulant Reversal Drug Sales by Region (2024-2034) & (K Units)
Table 44. Global Anticoagulant Reversal Drug Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Anticoagulant Reversal Drug Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Anticoagulant Reversal Drug Sales Market Share in Value by Region (2024-2034)
Table 47. Global Anticoagulant Reversal Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Anticoagulant Reversal Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Anticoagulant Reversal Drug Sales by Application (2018-2024) & (K Units)
Table 50. Global Anticoagulant Reversal Drug Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Anticoagulant Reversal Drug Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Anticoagulant Reversal Drug Sales Market Share in Value by Application (2018-2024)
Table 53. Global Anticoagulant Reversal Drug Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Anticoagulant Reversal Drug Sales by Application (2024-2034) & (K Units)
Table 55. Global Anticoagulant Reversal Drug Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Anticoagulant Reversal Drug Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Anticoagulant Reversal Drug Sales Market Share in Value by Application (2024-2034)
Table 58. Global Anticoagulant Reversal Drug Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Anticoagulant Reversal Drug Sales by Application (2018-2024) (K Units)
Table 60. North America Anticoagulant Reversal Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Anticoagulant Reversal Drug Sales by Application (2018-2024) (K Units)
Table 62. Europe Anticoagulant Reversal Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Anticoagulant Reversal Drug Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Anticoagulant Reversal Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Anticoagulant Reversal Drug Sales by Application (2018-2024) (K Units)
Table 66. Latin America Anticoagulant Reversal Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Anticoagulant Reversal Drug Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Anticoagulant Reversal Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Anticoagulant Reversal Drug Sales by Country (2018-2024) & (K Units)
Table 70. North America Anticoagulant Reversal Drug Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Anticoagulant Reversal Drug Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Anticoagulant Reversal Drug Sales Market Share in Value by Country (2018-2024)
Table 73. North America Anticoagulant Reversal Drug Sales by Country (2024-2034) & (K Units)
Table 74. North America Anticoagulant Reversal Drug Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Anticoagulant Reversal Drug Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Anticoagulant Reversal Drug Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Anticoagulant Reversal Drug Sales by Country (2018-2024) & (K Units)
Table 78. Europe Anticoagulant Reversal Drug Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Anticoagulant Reversal Drug Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Anticoagulant Reversal Drug Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Anticoagulant Reversal Drug Sales by Country (2024-2034) & (K Units)
Table 82. Europe Anticoagulant Reversal Drug Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Anticoagulant Reversal Drug Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Anticoagulant Reversal Drug Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Anticoagulant Reversal Drug Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Anticoagulant Reversal Drug Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Anticoagulant Reversal Drug Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Anticoagulant Reversal Drug Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Anticoagulant Reversal Drug Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Anticoagulant Reversal Drug Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Anticoagulant Reversal Drug Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Anticoagulant Reversal Drug Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Anticoagulant Reversal Drug Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Anticoagulant Reversal Drug Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Anticoagulant Reversal Drug Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Anticoagulant Reversal Drug Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Anticoagulant Reversal Drug Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Anticoagulant Reversal Drug Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Anticoagulant Reversal Drug Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Anticoagulant Reversal Drug Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Anticoagulant Reversal Drug Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Anticoagulant Reversal Drug Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Anticoagulant Reversal Drug Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Anticoagulant Reversal Drug Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Anticoagulant Reversal Drug Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Anticoagulant Reversal Drug Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Anticoagulant Reversal Drug Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Anticoagulant Reversal Drug Sales Market Share in Value by Country (2024-2034)
Table 109. Bausch Health Companies Company Information
Table 110. Bausch Health Companies Introduction and Business Overview
Table 111. Bausch Health Companies Anticoagulant Reversal Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Bausch Health Companies Anticoagulant Reversal Drug Product
Table 113. Bausch Health Companies Recent Development
Table 114. Pfizer Company Information
Table 115. Pfizer Introduction and Business Overview
Table 116. Pfizer Anticoagulant Reversal Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Pfizer Anticoagulant Reversal Drug Product
Table 118. Pfizer Recent Development
Table 119. Fresenius Kabi Company Information
Table 120. Fresenius Kabi Introduction and Business Overview
Table 121. Fresenius Kabi Anticoagulant Reversal Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Fresenius Kabi Anticoagulant Reversal Drug Product
Table 123. Fresenius Kabi Recent Development
Table 124. Amneal Pharmaceuticals Company Information
Table 125. Amneal Pharmaceuticals Introduction and Business Overview
Table 126. Amneal Pharmaceuticals Anticoagulant Reversal Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Amneal Pharmaceuticals Anticoagulant Reversal Drug Product
Table 128. Amneal Pharmaceuticals Recent Development
Table 129. Boehringer Ingelheim Company Information
Table 130. Boehringer Ingelheim Introduction and Business Overview
Table 131. Boehringer Ingelheim Anticoagulant Reversal Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Boehringer Ingelheim Anticoagulant Reversal Drug Product
Table 133. Boehringer Ingelheim Recent Development
Table 134. CSL Company Information
Table 135. CSL Introduction and Business Overview
Table 136. CSL Anticoagulant Reversal Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. CSL Anticoagulant Reversal Drug Product
Table 138. CSL Recent Development
Table 139. Octapharma Company Information
Table 140. Octapharma Introduction and Business Overview
Table 141. Octapharma Anticoagulant Reversal Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Octapharma Anticoagulant Reversal Drug Product
Table 143. Octapharma Recent Development
Table 144. Portola Pharmaceuticals Company Information
Table 145. Portola Pharmaceuticals Introduction and Business Overview
Table 146. Portola Pharmaceuticals Anticoagulant Reversal Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. Portola Pharmaceuticals Anticoagulant Reversal Drug Product
Table 148. Portola Pharmaceuticals Recent Development
Table 149. Perosphere Pharmaceuticals Company Information
Table 150. Perosphere Pharmaceuticals Introduction and Business Overview
Table 151. Perosphere Pharmaceuticals Anticoagulant Reversal Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. Perosphere Pharmaceuticals Anticoagulant Reversal Drug Product
Table 153. Perosphere Pharmaceuticals Recent Development
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. Anticoagulant Reversal Drug Market Trends
Table 157. Anticoagulant Reversal Drug Market Drivers
Table 158. Anticoagulant Reversal Drug Market Challenges
Table 159. Anticoagulant Reversal Drug Market Restraints
Table 160. Anticoagulant Reversal Drug Distributors List
Table 161. Anticoagulant Reversal Drug Downstream Customers
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Anticoagulant Reversal Drug Product Picture
Figure 2. Global Anticoagulant Reversal Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Anticoagulant Reversal Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Anticoagulant Reversal Drug Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Prothrombin Complex Concentrates
Figure 6. Global Prothrombin Complex Concentrates Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Vitamin K
Figure 8. Global Vitamin K Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Protamine
Figure 10. Global Protamine Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Tranexamic Acid
Figure 12. Global Tranexamic Acid Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Global Anticoagulant Reversal Drug Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Anticoagulant Reversal Drug Sales Market Share by Type in 2022 & 2034
Figure 15. North America Anticoagulant Reversal Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Anticoagulant Reversal Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Anticoagulant Reversal Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Anticoagulant Reversal Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Anticoagulant Reversal Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Anticoagulant Reversal Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Anticoagulant Reversal Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Anticoagulant Reversal Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Anticoagulant Reversal Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Anticoagulant Reversal Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Anticoagulant Reversal Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Anticoagulant Reversal Drug Revenue in 2022
Figure 27. Anticoagulant Reversal Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospital Pharmacies
Figure 29. Global Hospital Pharmacies Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Retail Pharmacies
Figure 31. Global Retail Pharmacies Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Global Anticoagulant Reversal Drug Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Anticoagulant Reversal Drug Sales Market Share by Application in 2022 & 2034
Figure 36. North America Anticoagulant Reversal Drug Sales Market Share in Volume by Application in 2022
Figure 37. North America Anticoagulant Reversal Drug Sales Market Share in Value by Application in 2022
Figure 38. Europe Anticoagulant Reversal Drug Sales Market Share in Volume by Application in 2022
Figure 39. Europe Anticoagulant Reversal Drug Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Anticoagulant Reversal Drug Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Anticoagulant Reversal Drug Sales Market Share in Value by Application in 2022
Figure 42. Latin America Anticoagulant Reversal Drug Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Anticoagulant Reversal Drug Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Anticoagulant Reversal Drug Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Anticoagulant Reversal Drug Manufacturing Cost Structure
Figure 47. Anticoagulant Reversal Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries